Flow Traders U.S.’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
909
-37
-4% -$37.8K 0.04% 396
2026
Q1
$870K Buy
+946
New +$959K 0.03% 499
2025
Q4
Sell
-418
Closed -$319K 1128
2025
Q3
$319K Sell
418
-39
-9% -$29K 0.01% 727
2025
Q2
$356K Buy
+457
New +$355K 0.01% 690
2025
Q1
Sell
-2,563
Closed -$1.98M 1158
2024
Q4
$1.98M Buy
+2,563
New +$2.12M 0.08% 220
2024
Q1
Sell
-565
Closed -$329K 971
2023
Q4
$329K Buy
+565
New +$330K 0.01% 592

Other funds holding LLY

Flow Traders U.S.'s LLY Position: Q2 2026 in Review

Flow Traders U.S. reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $37.8K and leaving 909 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #396.

Flow Traders U.S. first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.98M in Q4 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Flow Traders U.S. held 909 shares of Eli Lilly worth $1.09M as of Q2 2026.
  • Flow Traders U.S. sold 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 0.04% of Flow Traders U.S.'s portfolio in Q2 2026, its #396 holding.
  • Flow Traders U.S. first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • Flow Traders U.S.'s Eli Lilly position peaked at $1.98M in Q4 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.